Skip to Main content Skip to Navigation
Journal articles

Stimulation of wild-type, F508del- and G551D-CFTR chloride channels by non-toxic modified pyrrolo[2,3-b]pyrazine derivatives

Abstract : Cystic fibrosis (CF) is a major inherited disorder involving abnormalities of fluid and electrolyte transport in a number of different organs due to abnormal function of cystic fibrosis transmembrane conductance regulator (CFTR) protein. We recently identified a family of CFTR activators, which contains the hit: RP107 [7-n-butyl-6-(4-hydroxyphenyl)[5H]pyrrolo[2,3-b]pyrazine]. Here, we further evaluated the effect of the chemical modifications of the RP107-OH radical on CFTR activation. The replacement of the OH radical by a fluorine atom at position 2 (RP193) or 4 (RP185) significantly decreased the toxicity of the compounds without altering the ability to activate CFTR, especially for RP193. The nontoxic compound RP193 has no effect on cAMP production but stimulates the channel activity of wild-type CFTR in stably transfected CHO cells, in human bronchial epithelial NuLi-1 cells, and in primary culture of human bronchial epithelial cells (HBEC). Wholecell and single patch-clamp recordings showed that RP193 induced a linear, time-and voltage-independent current, which was fully inhibited by two different and selective CFTR inhibitors (CFTRinh-172 and GP inh 5a). Moreover, RP193 stimulates CFTR in temperaturerescued CuFi-1 (F508del/F508del) HBEC and in CHO cells stably expressing G551D-CFTR. This study shows that it is feasible to reduce cytotoxicity of chemical compounds without affecting their potency to activate CFTR and to rescue the class 2 F508del-CFTR and class 3 G551D-CFTR CF mutant activities.
Complete list of metadata

https://hal.archives-ouvertes.fr/hal-03192023
Contributor : Arnaud Billet Connect in order to contact the contributor
Submitted on : Wednesday, April 7, 2021 - 4:45:53 PM
Last modification on : Friday, April 9, 2021 - 3:21:25 AM
Long-term archiving on: : Thursday, July 8, 2021 - 7:49:47 PM

File

4- Danhoffer et al, Frontiers ...
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Luc Dannhoffer, Arnaud Billet, Mathilde Jollivet-Souchet, Patricia Melin-Heschel, Christelle Faveau, et al.. Stimulation of wild-type, F508del- and G551D-CFTR chloride channels by non-toxic modified pyrrolo[2,3-b]pyrazine derivatives. Frontiers in Pharmacology, Frontiers, 2011, 2, ⟨10.3389/fphar.2011.00048⟩. ⟨hal-03192023⟩

Share

Metrics

Record views

32

Files downloads

58